Poly(curcumin) Oral Rinse

Overview

Oral Mucositis is a painful side effect of anti-cancer chemo and radiation therapy impacting nearly 100% of head and neck cancer patients. The intense pain and hindered oral function can lead to delays or stopping of these life-saving therapies.

BAM has developed an oral mucoadhesive barrier that relieves the patient’s discomfort. Unlike other solutions on the market, BAM’s mucoadhesive holds coverage indicating properties to signal the need for reapplication.

Product Status

BAM is working towards a 510(k) submission and is actively seeking partners for commercialization. If you are interested in more information on our commercialization strategy and the future potential for this technology, please contact us through the link below or at the email: hilt@bgamaterials.com

Affiliate Company